CP-29474-22

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameCP-29474-22

Drug Alias NameCP-29474-22CP-19474-22

ClassificationSmall molecules

Mechanisms of ActionEnzymes inhibitorsRibosomal metabolic modulators

TargetsEnzymes

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsBacterial Infections

ATC CodeN/A